Can the combination of ablation and immunomodulation become the breakthrough of cancer treatment?
Diagn Interv Imaging
.
2018 Mar;99(3):121-122.
doi: 10.1016/j.diii.2018.02.002.
Authors
H Takaki
1
,
F H Cornelis
2
Affiliations
1
Department of Radiology, Hyogo College of Medicine, Hyogo, Japan. Electronic address: takakiharuyuki@gmail.com.
2
Sorbonne Université, Radiology Department, Tenon Hospital, 4, rue de la Chine, 75020 Paris, France.
PMID:
29524986
DOI:
10.1016/j.diii.2018.02.002
No abstract available
Publication types
Editorial
Comment
MeSH terms
Combined Modality Therapy
Humans
Immunomodulation*
Neoplasms*